17 results
8-K
EX-1.1
PRME
Prime Medicine Inc
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
, the “Applicable Regulatory Authorities”) applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage
S-3
EX-1.2
PRME
Prime Medicine Inc
3 Nov 23
Shelf registration
5:23pm
Authorities”) applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export
424B4
PRME
Prime Medicine Inc
21 Oct 22
Prospectus supplement with pricing info
4:47pm
) to rod photoreceptors. Given our lead Prime Editor is larger than AAV packaging capacity, we are using a split AAV system that delivers the Prime Editor
S-1/A
nz99rdlnsfh8zt h9t
13 Oct 22
IPO registration (amended)
10:51am
S-1
EX-10.13
lzs938j02q f3k9ux
23 Sep 22
IPO registration
4:12pm
S-1
EX-1.1
kelrgfhw
23 Sep 22
IPO registration
4:12pm
S-1
7lacusi
23 Sep 22
IPO registration
4:12pm
DRS/A
9ljyps
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
q81f8sut2ffmi
6 May 22
Draft registration statement (amended)
12:00am
DRS/A
a796vt
8 Apr 22
Draft registration statement (amended)
12:00am
DRS/A
gcq9m1w
25 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
pp7ethj m2
7 Mar 22
Draft registration statement (amended)
12:00am
DRS/A
2vw1tc ga4
4 Feb 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.13
hkjydflqsio
12 Jan 22
Draft registration statement (amended)
12:00am
DRS
9vacu31w0nijr1l8fj4
20 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next